Seeing Is Believing
Currently out of the existing stock ratings of Sean Wieland, 260 are a BUY (76.47%), 65 are a HOLD (19.12%), 15 are a SELL (4.41%).
Analyst Sean Wieland, carries an average stock price target met ratio of 73.32% that have a potential upside of 28.6% achieved within 217 days. Previously, Sean Wieland worked at PIPER SANDLER.
Sean Wieland’s has documented 695 price targets and ratings displayed on 31 stocks. The coverage was on Healthcare, Technology, Consumer Defensive sectors.
Most recent stock forecast was given on OMCL, Omnicell at 05-Aug-2024.
Analyst best performing recommendations are on HIMS (HIMS HERS HEALTH).
The best stock recommendation documented was for PHR (PHREESIA) at 12/9/2020. The price target of $56 was fulfilled within 1 day with a profit of $3.39 (6.44%) receiving and performance score of 64.44.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$12
$5.67 (89.57%)
$15
2 months 3 days ago
(06-Aug-2025)
1/4 (25%)
$4.64 (63.04%)
1
Hold
$8
$1.67 (26.38%)
$70
4 months 17 days ago
(22-May-2025)
1/3 (33.33%)
$0.58 (7.82%)
38
Hold
$9
$2.67 (42.18%)
$12
5 months 2 days ago
(07-May-2025)
2/3 (66.67%)
$2.04 (29.31%)
141
Hold
$8
$1.67 (26.38%)
$10
5 months 8 days ago
(01-May-2025)
3/3 (100%)
$0.59 (7.96%)
27
Hold
$7.5
$1.17 (18.48%)
$12
6 months ago
(09-Apr-2025)
3/5 (60%)
$0.25 (3.45%)
41
What Year was the first public recommendation made by Sean Wieland?